- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
144 Clinical Trials near Fargo, ND
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerFrexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
858 Participants Needed
Frexalimab for Multiple Sclerosis
Trial Details
Key Eligibility Criteria
1400 Participants Needed
Radiation Therapy for Cancer with Bone Metastasis
Trial Details
Key Eligibility Criteria
280 Participants Needed
Low Dose Tamoxifen for Breast Cancer
Trial Details
Key Eligibility Criteria
1156 Participants Needed
Retatrutide vs Tirzepatide for Obesity
Trial Details
Key Eligibility Criteria
800 Participants Needed
Tivozanib + Pembrolizumab for Kidney Cancer
Trial Details
Key Eligibility Criteria
1040 Participants Needed
Treatment Timing for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
1100 Participants Needed
Cetuximab + Pembrolizumab for Head and Neck Cancer
Trial Details
Key Eligibility Criteria
158 Participants Needed
Olaparib +/- Bevacizumab for Ovarian Cancer
Trial Details
Key Eligibility Criteria
880 Participants Needed
Radiation Therapy for Brain Metastasis
Trial Details
Key Eligibility Criteria
269 Participants Needed
Targeted Therapy vs. Chemotherapy for Thyroid Cancer
Trial Details
Key Eligibility Criteria
264 Participants Needed
Rituximab vs Mosunetuzumab for Follicular Lymphoma
Trial Details
Key Eligibility Criteria
600 Participants Needed
Chemotherapy vs Chemoradiotherapy for Rectal Cancer
Trial Details
Key Eligibility Criteria
250 Participants Needed
Nivolumab + Standard Treatment for Stomach and Esophageal Cancer
Trial Details
Key Eligibility Criteria
224 Participants Needed
Dinutuximab + Chemotherapy for High-Risk Neuroblastoma
Trial Details
Key Eligibility Criteria
478 Participants Needed
Chemotherapy for Pancreatic Cancer
Trial Details
Key Eligibility Criteria
100 Participants Needed
Chemotherapy + Immunotherapy vs. Immunotherapy for Advanced Lung Cancer
Trial Details
Key Eligibility Criteria
304 Participants Needed
Durvalumab + Chemotherapy for Breast Cancer
Trial Details
Key Eligibility Criteria
3680 Participants Needed
Blood Test and Immunotherapy for Bladder Cancer
Trial Details
Key Eligibility Criteria
992 Participants Needed
Zanubrutinib for Mantle Cell Lymphoma
Trial Details
Key Eligibility Criteria
421 Participants Needed
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
Shorter vs Usual Radiation Therapy for Prostate Cancer
Trial Details
Key Eligibility Criteria
1209 Participants Needed
Shorter Chemo-Immunotherapy Without Anthracyclines for Breast Cancer
Trial Details
Key Eligibility Criteria
2400 Participants Needed
Chemotherapy + Hormone Therapy for Breast Cancer
Trial Details
Key Eligibility Criteria
3960 Participants Needed
Focused Radiation vs Systemic Therapy for Kidney Cancer
Trial Details
Key Eligibility Criteria
472 Participants Needed
Pembrolizumab for Triple-Negative Breast Cancer
Trial Details
Key Eligibility Criteria
1295 Participants Needed
Inclisiran for Cardiovascular Disease Prevention
Trial Details
Key Eligibility Criteria
14012 Participants Needed
Radiation + Immunotherapy for Head and Neck Cancer
Trial Details
Key Eligibility Criteria
290 Participants Needed
BRAF-Targeted Therapy for Colon Cancer
Trial Details
Key Eligibility Criteria
1 Participants Needed
Radiation and HER2-Targeted Therapy for Breast Cancer
Trial Details
Key Eligibility Criteria
1300 Participants Needed
Chemotherapy + Immunotherapy for Esophageal and Gastric Cancer
Trial Details
Key Eligibility Criteria
382 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do clinical trials in Fargo, ND pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do clinical trials in Fargo, ND work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across trials in Fargo, ND 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Fargo, ND is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Fargo, ND several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a medical study in Fargo, ND?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest clinical trials in Fargo, ND?
Most recently, we added Ruxolitinib Cream for Hidradenitis Suppurativa, Radiation Therapy for Cancer with Bone Metastasis and Cetuximab + Pembrolizumab for Head and Neck Cancer to the Power online platform.